AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32152145
Drug: Ciliary neurotrophic
RxNorm normalized name: CILIARY NEUROTROPHIC FACTOR
DrugBank: Ciliary neurotrophic factor (DB05344)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciliary neurotrophic factor (CNTF) treatment
Trial: 33985435
Drug: Severe chemotherapy-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe chemotherapy-induced neutropenia (CIN)
Trial: 33985435
Drug: Mild chemotherapy-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild chemotherapy-induced neutropenia (CIN)
Trial: 33985435
Drug: Severe and
RxNorm normalized name: Daytime Severe and Nighttime Severe cold and flu KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe and mild chemotherapy-induced neutropenia (CIN) in out-of-landmark group
Trial: 35410754
Drug: Selumetinib granule
RxNorm normalized name: selumetinib
DrugBank: Selumetinib (DB11689)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selumetinib granule (25 mg)
Trial: 35410754
Drug: Selumetinib capsule
RxNorm normalized name: selumetinib
DrugBank: Selumetinib (DB11689)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selumetinib capsule (50 mg [2 x 25 mg])
Trial: 36641027
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (NT)
Trial: 34531537
Drug: Ibrutinib 420
RxNorm normalized name: ibrutinib 420 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibrutinib 420 mg once daily
Trial: 34687308
Drug: Dry needling
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry needling with conventional physical therapy
Trial: 34687308
Drug: Sham dry
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham dry needling with conventional physical therapy
Trial: 34370612
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (control group)
Trial: 34992881
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose radiation therapy (RT)
Trial: 36310517
Drug: Multimodal physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimodal physiotherapy intervention (exercise therapy and patient education)
Trial: 39691747
Drug: Standard analgesic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard analgesic treatment
Trial: 35425844
Drug: Control (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (3 mL of subcutaneous 0.5% bupivacaine)
Trial: 35425844
Drug: HVIGI (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HVIGI (10 mL of 0.5% bupivacaine and 30 mL of normal saline, ultrasound‐guided between tendon and underlying fat pad)
Trial: 35425844
Drug: HVIGI with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HVIGI with steroid (0.25 mL of 100 mg/mL hydrocortisone)
Trial: 34008857
Drug: Perampanel 4
RxNorm normalized name: perampanel 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perampanel 4 mg
Trial: 34008857
Drug: Perampanel 8
RxNorm normalized name: perampanel 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perampanel 8 mg
Trial: 35247102
Drug: Continuing ARB/CCB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing ARB/CCB combination tablets (Group C)
Trial: 35247102
Drug: Withholding ARB/CCB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withholding ARB/CCB combination tablets (Group W)
Trial: 34220581
Drug: Ketamine hydrochloride
RxNorm normalized name: Ketamine Hydrochloride
DrugBank: Ketamine (DB01221)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketamine hydrochloride (0.5 mg/kg)
Trial: 34780683
Drug: Milvexian (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milvexian (all doses)
Trial: 33419635
Drug: Weekly subcutaneous
RxNorm normalized name: Weekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly subcutaneous semaglutide
Trial: 34551146
Drug: Hydrophobic narrow-diameter
RxNorm normalized name: narrowleaf marshelder pollen extract
DrugBank: Iva angustifolia pollen (DB10968)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrophobic narrow-diameter implants (Neoporos surface, NS)
Trial: 34551146
Drug: Hydrophilic narrow-diameter
RxNorm normalized name: narrowleaf marshelder pollen extract
DrugBank: Iva angustifolia pollen (DB10968)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrophilic narrow-diameter implants (Acqua surface, AS)
Trial: 33593462
Drug: Synbiotic ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic ice cream supplementation for 30 days containing 2·1 × 10^8 CFU/g for Lactobacillus acidophilus LA‐5, 2·7 × 10^9 CFU/g for Bifidobacterium animalis BB‐12, and 2·3 g of inulin in 60 g of ice cream.
Trial: 33593462
Drug: Placebo ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ice cream.
Trial: 33593462
Drug: Synbiotic ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic ice cream supplementation.
Trial: 34789539
Drug: Stereotactic body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body radiation therapy
Trial: 34789539
Drug: Standard systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard systemic treatment
Trial: 37644215
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT)
Trial: 35246227
Drug: Midodrine 10
RxNorm normalized name: midodrine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine 10 mg administered enterally every 8 hours
Trial: 35020871
Drug: Racemic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic ketamine (0.5 mg/kg) infusions
Trial: 70648026
Drug: Ceftaroline fosamil
RxNorm normalized name: Ceftaroline fosamil
DrugBank: Ceftaroline fosamil (DB06590)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftaroline fosamil 600 mg q12h
Trial: 38000564
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg
Trial: 35297138
Drug: Intralesional PPD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional PPD monotherapy at 2-week intervals for up to six sessions
Trial: 34768411
Drug: Sham HILT
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham HILT therapy (placebo)
Trial: 32064794
Drug: Anlotinib (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anlotinib (12 mg QD from days 1 to 14 of a 21-day cycle)
Trial: 33618193
Drug: Integrated exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated exposure therapy
Trial: 33618193
Drug: Integrated coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated coping skills therapy
Trial: 33085787
Drug: Advances in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advances in immunotherapy for prostate cancer
Trial: 36111381
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of DIM (administered as 300 mg of DIM‐BR®) for 30 days
Trial: 33765679
Drug: Low-dose exercise
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose exercise training at 4-7 days/week
Trial: 39102624
Drug: Nivolumab 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 3 mg/kg every 2 weeks
Trial: 37180843
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg twice daily
Trial: 38153624
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg daily
Trial: 34750366
Drug: Disinfectant spray
RxNorm normalized name: Lysol Disinfectant Spray
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disinfectant spray
Trial: 34543939
Drug: Emotional intelligence
RxNorm normalized name: Intelence
DrugBank: Etravirine (DB06414)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Emotional intelligence training (twice a week for one month, then once a week for 11 months)
Trial: 32065620
Drug: Serelaxin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin (30 µg/kg/day, 48 hours intravenous infusion)
Trial: 36343592
Drug: Azithromycin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (20 mg/kg single oral dose)
Trial: 33530942
Drug: Low-dose TXA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose TXA
Trial: 33530942
Drug: High-dose TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose TXA
Trial: 32902312
Drug: Nivolumab (N)
DrugBank: Nivolumab (DB09035)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nivolumab (N) alone or combined with ipilimumab (I) as neoadjuvant therapy after 6 months of adjuvant therapy
Trial: 32902312
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy as first-line treatment
Trial: 35973802
Drug: Rituximab induction
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab induction therapy
Trial: 35022178
Drug: Psychosomatic therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosomatic therapy, delivered by specialised exercise and physical therapists, a multimodal and tailored treatment based on the biopsychosocial model.
Trial: 35022178
Drug: Psychosomatic therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosomatic therapy, delivered by specialised exercise and physical therapists.
Trial: 35663978
Drug: Neoadjuvant trastuzumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant trastuzumab and pertuzumab treatment
Trial: 32990633
Drug: Standard plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard plus weekly videoconferencing support (S+VCS)
Trial: 35274092
Drug: Low-dose azathioprine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose azathioprine (median dose 50 mg) combined with allopurinol (100 mg)
Trial: 35274092
Drug: Azathioprine monotherapy
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine monotherapy (median dose 200 mg)
Trial: 32444401
Drug: As-needed budesonide-formoterol
RxNorm normalized name: budesonide / formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As-needed budesonide-formoterol (200/6 μg Turbuhaler, one actuation)
Trial: 32444401
Drug: Maintenance budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Maintenance budesonide (200 μg Turbuhaler, one actuation twice a day) with as-needed terbutaline (250 μg, two actuations)
Trial: 36905485
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine U100
Trial: 32462206
Drug: Placebo moisturizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo moisturizer applied twice daily for 12 weeks
Trial: 33278832
Drug: Warfarin (GFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (GFR ≥ 45–59)
Trial: 33278832
Drug: Warfarin (GFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (GFR < 45)
Trial: 33278832
Drug: Warfarin (ARISTOTLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (ARISTOTLE and ENGAGE trials, GFR ≥ 45–59)
Trial: 33278832
Drug: Warfarin (ARISTOTLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (ARISTOTLE and ENGAGE trials, GFR < 45)
Trial: 33085861
Drug: AK002 (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AK002 (combined low-dose and high-dose)
Trial: 39284383
Drug: Pembrolizumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab plus chemotherapy
Trial: 34004416
Drug: ResistAid (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ResistAid (15 g/d)
Trial: 36336861
Drug: Single high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high oral dose of vitamin D3 (120,000 IU)
Trial: 33805193
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (CSI) applied to 15 patients (17 elbows)
Trial: 33805193
Drug: Rest-and-medication group
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rest-and-medication group (RMG) with 15 patients
Trial: 36914957
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no aspirin)
Trial: 32926760
Drug: Concurrent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent treatment
Trial: 35419799
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 mL normal saline)
Trial: 33988725
Drug: Tradipitant 85
RxNorm normalized name: Tradipitant
DrugBank: Tradipitant (DB12580)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tradipitant 85 mg/bid
Trial: 33988725
Drug: Oxycodone (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (0 to 30 mg)
Trial: 32565318
Drug: Neoadjuvant and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant and concurrent ADT for 6 months starting 4 months before prostate radiation therapy (NHT arm)
Trial: 32565318
Drug: Concurrent and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent and adjuvant ADT for 6 months starting simultaneously with radiation therapy (CAHT arm)
Trial: 36625789
Drug: Intravenous pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pamidronate
Trial: 34419676
Drug: 5-aminolevulinic acid
RxNorm normalized name: 5-aminolevulinic acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT)
Trial: 33185380
Drug: Aspirin-treated group
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin-treated group
Trial: 33142541
Drug: Organic zinc
RxNorm normalized name: ZINC OXIDE 25 g in 100 g TOPICAL LOTION [ORGANIC ZINCLEAR SUNSCREEN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organic zinc (zinc amino acid complex) at low (35 mg/kg) and high (70 mg/kg) levels
Trial: 33142541
Drug: Inorganic zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inorganic zinc (zinc sulfate) at low (35 mg/kg) and high (70 mg/kg) levels
Trial: 32644104
Drug: Fluorouracil-based adjuvant
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil-based adjuvant chemotherapy
Trial: 34949506
Drug: Control (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (normal saline, 20 mL) administered intravenously
Trial: 34462287
Drug: Chemotherapy (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (cisplatin or carboplatin plus pemetrexed)
Trial: 33072620
Drug: L-thyroxine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine treatment
Trial: 36195164
Drug: Intraurethral prilocaine
RxNorm normalized name: Prilocaine
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraurethral prilocaine solution
Trial: 36195164
Drug: Intraurethral lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraurethral lidocaine gel
Trial: 33706573
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy / Mindfulness Based Stress Reduction intervention
Trial: 34213493
Drug: Intrathecal buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal buprenorphine (0.5 mL, 60 mg) with 3 mL of heavy (0.5%) hyperbaric bupivacaine
Trial: 34384597
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (NSS 20 mL before skin incision and at 3 hours after surgery)
Trial: 34384597
Drug: One-dose (1D)
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose (1D) group (750 mg TXA before skin incision and NSS 20 mL at 3 hours after surgery)
Trial: 34384597
Drug: Two-dose (2D)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose (2D) group (750 mg TXA before skin incision and 750 mg TXA at 3 hours after surgery)
Trial: 32216814
Drug: GSK3008348 (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3008348 (1000 mcg nebulised dose)
Trial: 32867986
Drug: Standard BW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard BW treatment with 12L:12D rearing photoschedule
Trial: 38715179
Drug: Dulaglutide 1.5
RxNorm normalized name: dulaglutide 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide 1.5 mg
Trial: 33408531
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose complex (ISC)
Trial: 32220771
Drug: Mannitol plus
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol plus hypertonic saline combination (MHS)
Trial: 32220771
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline monotherapy (HS)
Trial: 34811841
Drug: Basic Body
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic Body Awareness Therapy (BBAT)
Trial: 32753750
Drug: Cooling therapy
RxNorm normalized name: MENTHOL 2.8 g in 56 g TOPICAL CREAM [elevate COOLING THERAPY TWIST UP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooling therapy
Trial: 32173802
Drug: Parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib 40 mg 30 minutes before induction
Trial: 32734238
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution
Trial: 33406277
Drug: ACT-1004-1239 (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT-1004-1239 (doses 1-200 mg)
Trial: 33051029
Drug: Individual cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive behavioral therapy (ICBT) delivered in research settings
Trial: 33051029
Drug: Individual cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual cognitive behavioral therapy (ICBT) delivered in community settings
Trial: 34269720
Drug: Dexamethasone (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (16 mg) and 20% albumin (100 mL) at induction of anesthesia, then 200 mL of 20% albumin with each subsequent 1000 mL of crystalloid administered (Dex‐Alb group)
Trial: 33416500
Drug: Sham rTMS
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham rTMS treatment
Trial: 35877195
Drug: Favipiravir tablet
RxNorm normalized name: favipiravir
DrugBank: Favipiravir (DB12466)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Favipiravir tablet (200 mg)
Trial: 39620432
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus radiotherapy
Trial: 33462582
Drug: Azithromycin 1
RxNorm normalized name: azithromycin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 1 g orally once weekly for 3 weeks
Trial: 33462582
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice daily for 21 days
Trial: 36036087
Drug: Low-dose vonoprazan-amoxicillin
RxNorm normalized name: vonoprazan, amoxicillin and clarithromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose vonoprazan-amoxicillin dual therapy (amoxicillin 1 g b.i.d. for 7 or 10 days, vonoprazan 20 mg b.i.d.)
Trial: 37025023
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg
Trial: 33176205
Drug: Meningococcal Conjugate
RxNorm normalized name: meningococcal conjugate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal Conjugate Vaccine (MCV-A) and control vaccine (inactivated polio vaccine)
Trial: 32273234
Drug: Docetaxel chemotherapy
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel chemotherapy
Trial: 35544387
Drug: Subcutaneous lenacapavir
RxNorm normalized name: Lenacapavir
DrugBank: Lenacapavir (DB15673)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous lenacapavir every 6 months with optimized background therapy (Cohort 2)
Trial: 37833651
Drug: Open-label placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label placebo (OLP) treatment
Trial: 33226999
Drug: Non-nucleoside reverse
RxNorm normalized name: Non-nucleoside reverse transcriptase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-nucleoside reverse transcriptase inhibitor
Trial: 33226999
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor vs. Non-nucleoside reverse transcriptase inhibitor
Trial: 34872717
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron (ferric carboxymaltose 1000 mg i.v.)